| scholarly article | Q13442814 |
| P50 | author | Shu-Qun Cheng | Q88589245 |
| P2093 | author name string | Ning Ma | |
| Dong Xie | |||
| Jing-Jing Li | |||
| Xiu-Ping Zhang | |||
| Er-Bin Zhang | |||
| Yu-Zhen Gao | |||
| Ya-Bo Jiang | |||
| Yan-Mei Yuan | |||
| Cheng-Qian Zhong | |||
| Shi-Qian Lan | |||
| P2860 | cites work | Fatty acids in cell signalling: modulation by lipid binding proteins | Q28303482 |
| Fatty acid-binding protein 5 function in hepatocellular carcinoma through induction of epithelial-mesenchymal transition | Q33679605 | ||
| Cytoplasmic fatty acid binding protein sensing fatty acids for peroxisome proliferator activated receptor activation | Q36944773 | ||
| Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC). | Q37564704 | ||
| Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies. | Q37904165 | ||
| Advanced HCC: emerging molecular therapies | Q37993765 | ||
| Krüppel-like factors in hepatocellular carcinoma | Q38344470 | ||
| Identification of Downstream Genes of the mTOR Pathway that Predict Recurrence and Progression in Non-Muscle Invasive High-Grade Urothelial Carcinoma of the Bladder. | Q38431806 | ||
| Gene expression patterns combined with network analysis identify hub genes associated with bladder cancer | Q38464217 | ||
| The effects of androgen deprivation therapy with weight management on serum aP2 and adiponectin levels in prostate cancer patients | Q39032205 | ||
| EGFR and VEGFR as potential target for biological therapies in HCC cells. | Q40016766 | ||
| Involvement of IFN regulatory factor (IRF)-1 and IRF-2 in the formation and progression of human esophageal cancers | Q40158385 | ||
| Detection of transcript for brain-type fatty Acid-binding protein in tumor and urine of patients with renal cell carcinoma | Q40167171 | ||
| A-FABP, a candidate progression marker of human transitional cell carcinoma of the bladder, is differentially regulated by PPAR in urothelial cancer cells. | Q42607754 | ||
| Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study. | Q45980006 | ||
| Altered fatty acid-binding protein 4 (FABP4) expression and function in human and animal models of hepatocellular carcinoma. | Q47368821 | ||
| 20(S)-25-methoxyl-dammarane-3β, 12β, 20-triol negatively regulates activation of STAT3 and ERK pathways and exhibits anti-cancer effects in HepG2 cells | Q47726020 | ||
| Fatty acid binding protein 4 promotes epithelial-mesenchymal transition in cervical squamous cell carcinoma through AKT/GSK3β/Snail signaling pathway. | Q47821511 | ||
| Distinction immune genes of hepatitis-induced heptatocellular carcinoma | Q47946583 | ||
| MEK-ERK inhibition potentiates WAY-600-induced anti-cancer efficiency in preclinical hepatocellular carcinoma (HCC) models. | Q53116412 | ||
| Association and coexpression of fatty-acid-binding protein and glycoprotein CD36 in the bovine mammary gland | Q71699856 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 2629-2640 | |
| P577 | publication date | 2018-05-07 | |
| P1433 | published in | Cancer Medicine | Q27724564 |
| P1476 | title | FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma | |
| P478 | volume | 7 |
| Q103007648 | Combination of canstatin and arsenic trioxide suppresses the development of hepatocellular carcinoma |
| Q99634783 | Cross-Species Proteomics Identifies CAPG and SBP1 as Crucial Invasiveness Biomarkers in Rat and Human Malignant Mesothelioma |
| Q64053363 | FABP4 contributes to renal interstitial fibrosis via mediating inflammation and lipid metabolism |
| Q92382925 | FIBCD1 overexpression predicts poor prognosis in patients with hepatocellular carcinoma |
| Q64079418 | Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases |
| Q104130649 | Fatty acid binding protein-4 promotes alcohol-dependent hepatosteatosis and hepatocellular carcinoma progression |
| Q98770571 | Important players in carcinogenesis as potential targets in cancer therapy: an update |
| Q64981845 | Prognostic and clinicopathological significance of Gamma-Glutamyltransferase in patients with hepatocellular carcinoma: A PRISMA-compliant meta-analysis. |
| Q91776664 | Study of Gene Expression Profiles of Breast Cancers in Indian Women |
| Q58615612 | The prognostic significance of pretreatment serum Gamma-glutamyltranspeptidase in primary liver cancer: A meta-analysis and systematic review |
Search more.